Implant traceability: EU has failed and regulations are needed
This article was originally published in RAJ Devices
In light of the European Commission's ongoing work on the recast of the medical device directives, every aspect of EU device regulation is potentially up for scrutiny. Subsequently, now may be the right time for the matter of implant traceability to be examined more closely and an urgent legal change to be sought.
You may also be interested in...
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests not sufficiently accurate to be used in the pandemic.